These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 23866421)

  • 21. Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study.
    Niccoli L; Nannini C; Benucci M; Chindamo D; Cassarà E; Salvarani C; Cimino L; Gini G; Lenzetti I; Cantini F
    Rheumatology (Oxford); 2007 Jul; 46(7):1161-4. PubMed ID: 17478466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-TNF-α therapy in patients with refractory uveitis due to Behçet's disease: a 1-year follow-up study of 124 patients.
    Calvo-Río V; Blanco R; Beltrán E; Sánchez-Bursón J; Mesquida M; Adán A; Hernandez MV; Hernandez Garfella M; Valls Pascual E; Martínez-Costa L; Sellas-Fernández A; Cordero Coma M; Díaz-Llopis M; Gallego R; Salom D; García Serrano JL; Ortego N; Herreras JM; Fonollosa A; García-Aparicio AM; Maíz O; Blanco A; Torre I; Fernández-Espartero C; Jovani V; Peiteado-Lopez D; Pato E; Cruz J; Fernández-Cid C; Aurrecoechea E; García M; Caracuel MA; Montilla C; Atanes A; Hernandez FF; Insua S; González-Suárez S; Sánchez-Andrade A; Gamero F; Linares L; Romero-Bueno F; García AJ; Almodovar R; Minguez E; Carrasco Cubero C; Olive A; Vázquez J; Ruiz Moreno O; Jiménez-Zorzo F; Manero J; Muñoz Fernández S; Rueda-Gotor J; González-Gay MA
    Rheumatology (Oxford); 2014 Dec; 53(12):2223-31. PubMed ID: 24996907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Remission of Behcet's disease with anti-tumor necrosis factor monoclonal antibody therapy: a case report.
    Gulli S; Arrigo C; Bocchino L; Morgante L; Sangari D; Castagna I; Bagnato GF
    BMC Musculoskelet Disord; 2003 Aug; 4():19. PubMed ID: 12946278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An attack of acute neuro-Behçet's disease during the course of chronic progressive neuro-Behçet's disease: report of two cases.
    Matsui T; Ishida T; Tono T; Yoshida T; Sato S; Hirohata S
    Mod Rheumatol; 2010 Dec; 20(6):621-6. PubMed ID: 20617356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bilateral intraocular inflammation after intravitreal bevacizumab in Behcet's disease.
    Bae JH; Lee SC
    Eye (Lond); 2010 Apr; 24(4):735. PubMed ID: 19543240
    [No Abstract]   [Full Text] [Related]  

  • 26. Psoriasis triggered by infliximab in a patient with Behçet's disease.
    Kawazoe Y; Sugita S; Yamada Y; Akino A; Miura K; Mochizuki M
    Jpn J Ophthalmol; 2013 Jan; 57(1):95-7. PubMed ID: 23090423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infliximab treatment for severe orogenital ulceration in Behçet's disease.
    Connolly M; Armstrong JS; Buckley DA
    Br J Dermatol; 2005 Nov; 153(5):1073-5. PubMed ID: 16225632
    [No Abstract]   [Full Text] [Related]  

  • 28. Long-lasting remission of severe Behçet's disease after the end of infliximab therapy.
    Olivieri I; Padula A; Leccese P; D'Angelo S; Giasi V
    J Rheumatol; 2009 Apr; 36(4):855. PubMed ID: 19342728
    [No Abstract]   [Full Text] [Related]  

  • 29. Behçet's disease ocular attack score 24: evaluation of ocular disease activity before and after initiation of infliximab.
    Kaburaki T; Namba K; Sonoda KH; Kezuka T; Keino H; Fukuhara T; Kamoi K; Nakai K; Mizuki N; Ohguro N;
    Jpn J Ophthalmol; 2014 Mar; 58(2):120-30. PubMed ID: 24482146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of regulatory T cells by infliximab in Behcet's disease.
    Sugita S; Yamada Y; Kaneko S; Horie S; Mochizuki M
    Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):476-84. PubMed ID: 20861484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Results of immunosuppressive treatment in Bechçet's disease: report of 55 cases.
    Firat T
    Ann Ophthalmol; 1978 Oct; 10(10):1421-3. PubMed ID: 718044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Behçet's disease: successful treatment with infliximab in 7 patients with severe vascular manifestations. A retrospective analysis.
    Adler S; Baumgartner I; Villiger PM
    Arthritis Care Res (Hoboken); 2012 Apr; 64(4):607-11. PubMed ID: 22162223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conjunctival ulcers in Behçet's disease.
    Zamir E; Bodaghi B; Tugal-Tutkun I; See RF; Charlotte F; Wang RC; Wechsler B; LeHoang P; Anteby I; Rao NA
    Ophthalmology; 2003 Jun; 110(6):1137-41. PubMed ID: 12799237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Behçet's disease.
    Bonfioli AA; Orefice F
    Semin Ophthalmol; 2005; 20(3):199-206. PubMed ID: 16282155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Behçet's disease].
    Aouba A
    Rev Prat; 2008 Mar; 58(5):533-40. PubMed ID: 18524110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination therapy of infliximab and thalidomide for refractory entero-Behcet's disease: a case report.
    Li Y; Han Z; Wang X; Mo Z; Zhang W; Li A; Liu S
    BMC Gastroenterol; 2013 Dec; 13():167. PubMed ID: 24321021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cytostatic and immunosuppressive treatment of ocular Behçet syndrome].
    Schilling H; Bornfeld N; Windeck R; Wessing A; Kirch W
    Klin Monbl Augenheilkd; 1990 Feb; 196(2):62-9. PubMed ID: 2325343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical observation of 85 patients with Behçet's uveitis treated with immunosuppressive agents combined with steroids].
    Zhao M; Wang H; Jiao X; Wei WB
    Zhonghua Yan Ke Za Zhi; 2013 Mar; 49(3):202-6. PubMed ID: 23866699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased ocular inflammatory attacks and background retinal and disc vascular leakage in patients with Behcet's disease on infliximab therapy.
    Keino H; Okada AA; Watanabe T; Taki W
    Br J Ophthalmol; 2011 Sep; 95(9):1245-50. PubMed ID: 21183514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful treatment of genital ulcers with infliximab in Behcet's disease.
    Haugeberg G; Velken M; Johnsen V
    Ann Rheum Dis; 2004 Jun; 63(6):744-5. PubMed ID: 15140785
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.